Don’t Jump to Nurtec ODT for Migraine Prevention in Adults

August 2021

Nurtec ODT (rimegepant) will now be used for migraine PREVENTION in adults...in addition to acute treatment.

It blocks receptors of calcitonin gene-related peptide (CGRP), a vasodilator and pain sensitizer that spikes during migraine attacks.

Until recently, only the INJECTABLE CGRP antagonists (Aimovig, etc) were approved for prevention.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote